4.5 Article

Mitochondrial pyruvate import and its effects on homeostasis

Journal

CURRENT OPINION IN CELL BIOLOGY
Volume 33, Issue -, Pages 35-41

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.ceb.2014.10.008

Keywords

-

Categories

Funding

  1. Swiss National Science Foundation [31003A-141068/1]
  2. La ligue Genevoise contre le cancer
  3. Sinergia [CRSII3_147637/1]
  4. iGE3
  5. State of Geneva
  6. Medical Research Council UK
  7. Deutsche Forschungsgemeinschaft [BE5103/1-1]
  8. Swiss National Science Foundation (SNF) [31003A_141068, CRSII3_147637] Funding Source: Swiss National Science Foundation (SNF)
  9. Medical Research Council [MC_U105663139] Funding Source: researchfish
  10. MRC [MC_U105663139] Funding Source: UKRI

Ask authors/readers for more resources

Pyruvate metabolism plays a pivotal role in cell homeostasis and energy production. Pyruvate, the end product of glycolysis, is either catabolized in the cytosol, or enters into mitochondria to promote oxidative phosphorylation. The import of pyruvate into mitochondria requires a specific carrier in the inner mitochondrial membrane, the mitochondrial pyruvate carrier (MPC), whose identity was only recently discovered. Here we report our current knowledge of the structure and function of the MPC and we describe how dysfunction of the MPC could participate in various pathologies, including type 2 diabetes and cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Structural Mechanism of Transport of Mitochondrial Carriers

J. J. Ruprecht, E. R. S. Kunji

Summary: Members of the mitochondrial carrier family transport a variety of molecules across the mitochondrial inner membrane, playing crucial roles in cellular processes. The transport mechanism involves a central substrate-binding site, gates with salt-bridge networks, and conformational changes triggered by substrate binding during import and export.

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 90, 2021 (2021)

Review Biochemistry & Molecular Biology

RNA Granules in the Mitochondria and Their Organization under Mitochondrial Stresses

Vanessa Joanne Xavier, Jean-Claude Martinou

Summary: The human mitochondrial genome regulates its transcription products in specialized ways through mtDNA, with RNA regulation organized within the Mitochondrial RNA Granules. Recent findings show that dsRNA species can form granules in the mitochondria matrix. Dysfunctions in mitochondria, such as RNA processing defects, may lead to loss or aberrant accumulation of these RNA granules, emphasizing the link between mitochondrial maintenance and proper gene expression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biophysics

Structure, substrate binding, and symmetry of the mitochondrial ADP/ATP carrier in its matrix-open state

Joel Jose Montalvo-Acosta, Edmund R. S. Kunji, Jonathan J. Ruprecht, Francois Dehez, Christophe Chipot

Summary: Research has shown that cardiolipins play a minor stabilizing role in the structure of the mitochondrial ADP/ATP carrier (AAC), particularly in the formation of interdomain salt bridges and hydrogen bonds. Additionally, cardiolipins contribute to preserving the pseudosymmetric structure of AAC, making it more compactly organized.

BIOPHYSICAL JOURNAL (2021)

Article Genetics & Heredity

The FASTK family proteins fine-tune mitochondrial RNA processing

Akira Ohkubo, Lindsey S. Van Haute, Danielle Rudler, Maike S. Stentenbach, Florian Steiner, Oliver S. Rackham, Michal Minczuk, Aleksandra S. Filipovska, Jean-Claude Martinou

Summary: Mitochondria have a unique gene expression system involving canonical and non-canonical RNA processing, with FASTK family proteins playing a crucial role in regulating RNA junctions. Disruption of the FASTKD5 gene results in defects in mitochondrial translation and oxidative phosphorylation, highlighting the importance of FASTK protein family members in non-canonical RNA processing in mitochondria.

PLOS GENETICS (2021)

Article Endocrinology & Metabolism

Key features of inhibitor binding to the human mitochondrial pyruvate carrier hetero-dimer

Sotiria Tavoulari, Tom J. J. Schirris, Vasiliki Mavridou, Chancievan Thangaratnarajah, Martin S. King, Daniel T. D. Jones, Shujing Ding, Ian M. Fearnley, Edmund R. S. Kunji

Summary: This study characterized the human mitochondrial pyruvate carrier (MPC) protein and identified the chemical features necessary for high-affinity inhibition. It found that three hydrogen bond acceptors followed by an aromatic ring are shared characteristics of all inhibitors and represent the minimal requirement for high potency. The study also discovered 14 new MPC inhibitors, with one compound outperforming a known inhibitor by tenfold.

MOLECULAR METABOLISM (2022)

Article Clinical Neurology

TMEM63C mutations cause mitochondrial morphology defects and underlie hereditary spastic paraplegia

Luis Carlos Tabara, Fatema Al-Salmi, Reza Maroofian, Amna Mohammed Al-Futaisi, Fathiya Al-Murshedi, Joanna Kennedy, Jacob O. Day, Thomas Courtin, Aisha Al-Khayat, Hamid Galedari, Neda Mazaheri, Margherita Protasoni, Mark Johnson, Joseph S. Leslie, Claire G. Salter, Lettie E. Rawlins, James Fasham, Almundher Al-Maawali, Nikol Voutsina, Perrine Charles, Laura Harrold, Boris Keren, Edmund R. S. Kunji, Barbara Vona, Gholamreza Jelodar, Alireza Sedaghat, Gholamreza Shariati, Henry Houlden, Andrew H. Crosby, Julien Prudent, Emma L. Baple

Summary: Hereditary spastic paraplegia (HSP), a genetically diverse neurodegenerative disease, can be classified as pure or complex forms. Biallelic variants in the TMEM63C gene were identified in individuals with HSP and mild intellectual disability. Further analysis showed that TMEM63C plays a role in regulating both endoplasmic reticulum and mitochondrial morphologies.

BRAIN (2022)

Review Endocrinology & Metabolism

Pathogenic variants of the mitochondrial aspartate/glutamate carrier causing citrin deficiency

Sotiria Tavoulari, Denis Lacabanne, Chancievan Thangaratnarajah, Edmund R. S. Kunji

Summary: Citrin deficiency is a globally prevalent mitochondrial disease with three stages: neonatal intrahepatic cholestasis, a mild adaptation stage, and adult citrullinemia. It is caused by the absence or dysfunction of the calcium-regulated mitochondrial aspartate/glutamate carrier 2 (AGC2/SLC25A13), also known as citrin. This deficiency affects the malate-aspartate shuttle, gluconeogenesis, amino acid homeostasis, and the urea cycle.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2022)

Article Multidisciplinary Sciences

Substrate binding in the mitochondrial ADP/ATP carrier is a step-wise process guiding the structural changes in the transport cycle

Vasiliki Mavridou, Martin S. King, Sotiria Tavoulari, Jonathan J. Ruprecht, Shane M. Palmer, Edmund R. S. Kunji

Summary: The authors investigate the molecular details of substrate binding in the mitochondrial ADP/ATP carrier, revealing the binding site and key residues involved in the transport process. This finding contributes to a better understanding of the mechanism and properties of adenine nucleotide transport.

NATURE COMMUNICATIONS (2022)

Article Endocrinology & Metabolism

Activating ligands of Uncoupling protein 1 identified by rapid membrane protein thermostability shift analysis

Riccardo Cavalieri, Marlou Klein Hazebroek, Camila A. Cotrim, Yang Lee, Edmund R. S. Kunji, Martin Jastroch, Susanne Keipert, Paul G. Crichton

Summary: This study elucidates the interaction between activators and UCP1, and demonstrates the potential of targeting UCP1 in cells as a therapeutic avenue using approved drugs, but requires variants with more effective delivery in brown adipocytes.

MOLECULAR METABOLISM (2022)

Article Biochemistry & Molecular Biology

Human mitochondrial ADP/ATP carrier SLC25A4 operates with a ping-pong kinetic mechanism

Camila Cimadamore-Werthein, Stephany Jaiquel Baron, Martin S. King, Roger Springett, Edmund R. S. Kunji

Summary: The mitochondrial ADP/ATP carrier plays a crucial role in oxidative phosphorylation by importing ADP into the mitochondrial matrix and exporting ATP. Recent studies have revealed that the carrier functions as a monomer with a single substrate binding site and operates with a ping-pong kinetic mechanism. These findings reconcile the discrepancy between the previous assumptions and provide insights into the alternating access mechanism of the carrier.

EMBO REPORTS (2023)

Article Multidisciplinary Sciences

Mitochondrial pyruvate metabolism regulates the activation of quiescent adult neural stem cells

Francesco Petrelli, Valentina Scandella, Sylvie Montessuit, Nicola Zamboni, Jean-Claude Martinou, Marlen Knobloch

Summary: Cellular metabolism plays a crucial role in the behavior of adult neural stem/progenitor cells (NSPCs). The mitochondrial pyruvate carrier (MPC) is identified as an important factor in controlling NSPC quiescence and activation.

SCIENCE ADVANCES (2023)

Article Multidisciplinary Sciences

Structural basis of purine nucleotide inhibition of human uncoupling protein 1

Scott A. Jones, Prerana Gogoi, Jonathan J. Ruprecht, Martin S. King, Yang Lee, Thomas Zogg, Els Pardon, Deepak Chand, Stefan Steimle, Danielle M. Copeman, Camila A. Cotrim, Jan Steyaert, Paul G. Crichton, Vera Moiseenkova-Bell, Edmund R. S. Kunji

Summary: Mitochondrial uncoupling protein 1 (UCP1) is responsible for the ability of brown adipose tissue in mammals to burn calories as heat for thermoregulation. UCP1 can be activated by fatty acids to generate heat by catalyzing the leakage of protons across the mitochondrial inner membrane. However, purine nucleotides can bind and inhibit UCP1, regulating proton leak through an unknown molecular mechanism. The cryo-electron microscopy structure of the GTP-inhibited state of UCP1 provides insights into the specific interactions and pH dependency of the regulatory mechanism, indicating that inhibitor binding prevents the conformational changes necessary for proton leak.

SCIENCE ADVANCES (2023)

Review Physiology

Fifty years of the mitochondrial pyruvate carrier: New insights into its structure, function, and inhibition

Sotiria Tavoulari, Maximilian Sichrovsky, Edmund R. S. Kunji

Summary: Mitochondrial pyruvate carrier (MPC) plays a crucial role in connecting cytosolic and mitochondrial metabolism by transporting pyruvate into the mitochondrial matrix. Due to its importance, MPC has been proposed as a potential target for various diseases. However, the knowledge about its structure and mechanism is limited. This article provides critical insights into the composition, structure, and function of MPC, and summarizes the different classes of small molecule inhibitors and their potential in therapeutics.

ACTA PHYSIOLOGICA (2023)

Article Biochemistry & Molecular Biology

The free-living flagellate Paratrimastix pyriformis uses a distinct mitochondrial carrier to balance adenine nucleotide pools

Justyna Zitek, Martin S. King, Priscila Pen, Eva Pyrihov, Alannah C. King, Edmund R. S. Kunji, Vladimir Hampl

Summary: Paratrimastix pyriformis is a free-living flagellate belonging to the group Metamonada and it has a mitochondrion-related organelle involved in one-carbon folate metabolism. The organelle contains solute carrier family 25 (SLC25) members responsible for metabolite exchange across the mitochondrial inner membrane. PpMC1, the adenine nucleotide carrier, was shown to transport ATP, ADP, and to a lesser extent, AMP, but not phosphate. It represents a distinct class of adenine nucleotide carriers different from ADP/ATP carriers and ATP-Mg/phosphate carriers.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2023)

Article Medicine, Research & Experimental

Characterization of drug-induced human mitochondrial ADP/ATP carrier inhibition

Stephany Jaiquel Baron, Martin S. King, Edmund R. S. Kunji, Tom J. J. Schirris

Summary: An increasing number of commonly prescribed drugs are known to interfere with mitochondrial function, causing cellular toxicity. However, the underlying mechanisms are largely unknown, and it has been found that only a subset of the 18 published AAC inhibitors can inhibit cellular respiratory capacity, raising questions about the effectiveness of all compounds in inhibiting this central metabolic process. Further research has provided new insights into the chemical compound features important for inhibition of mitochondrial transport proteins.

THERANOSTICS (2021)

No Data Available